Watch Bluestar Adisseo Co for free: we tell you when fair value or trend changes.

Bluestar Adisseo Co (600299) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Bluestar Adisseo Co stock ¥5.94, price ¥8.43, that is 29.5% below the price, quality 53 out of 100. Rating: overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

16 models, one by oneBear ¥5.06 to bull ¥7.73 Growth analysisrevenue history, year by year Quality 53/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials CN · ISIN CNE000001253

Broad data Nov 4, 2026

Bluestar Adisseo Co

600299 · SHG

Expensive, in a downtrend

Our calculation puts a fair price 30% below what the stock costs today.

Low debt

Generates free cash flow over the last twelve months

Ranks above peers (10/13)

Broad data

Last quarter vs. a year ago: revenue +26%, profit +174%.

Quality 53/100

Expensive Growth (revenue 5y +7.7 %/yr in CNY)

Thin margins · 9.4% net margin (TTM)

1.2% dividend yield · Watch coverage

Moderate moat 50/100 · thin data

Fair value ¥5.94 · Overvalued

⟳ Cyclical

Watch Bluestar Adisseo Co for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

60‑month range ¥6.75 – ¥15.46 · fair‑value band ¥5.06 – ¥7.73 · the ¥8.43 price screens above the ¥5.94 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 4, 2026.

Follow Bluestar Adisseo Co in your weekly email

Every Wednesday you see whether Bluestar Adisseo Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives.

Show moreShow less

The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT88, Rhodimet NP99, Microvit A Supra 1000, and Microvit E Promix 50; milk production product, such as MetaSmart; and sulfur-based products, which includes Rhodimet AT88, Rhodimet® NP99, Microvit A Supra 1000, and Microvit E Promix 50. In addition, the company offers mycotoxin management products, such as Unike Plus, Unike, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, and Delistart, as well as essential nutrient products, such as Rhodimet AT88, a hydroxy-methionine in liquid form; and Microvit A Supra 1000 to deliver performance; Microvit E Promix 50, a specialized nutritional supplement of vitamin E; and AdiSodium, which helps monogastrics to livestock management.

Further, it provides various services consisting of PNE, a near infra-red spectroscopy technology; MYCOMAN for the management of mycotoxins; ADICT, a nutritional values calculation tool; Predictor, a tool to help extract the value from feed; E.lab, a broad range of laboratory analyses to help feed and premix producers control the quality of raw materials and additives; DIM, a full support program; MilkPay calculator; Milk$MART; and NESTOR, which is used to formulate net energy.

It operates in China, Europe, the Middle East, Africa, the Indian subcontinent, North and south America, the Asia-Pacific regions. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company operates as a subsidiary of China National Bluestar (Group) Co,Ltd.

Stock analysis

Bluestar Adisseo Co (600299) currently trades at ¥8.43, while our model-based Fair Value estimate is ¥5.94, 30% below the price, so the stock looks overvalued today.

Valuation

Bull case: the Multiples group reads highest at a median of ¥8.12 per share, and 3 of the 16 models we run sit above the ¥8.43 price.

Bear case: the Dividend Discount group reads lowest at ¥3.25, and 13 of the 16 models stay below the price. Data coverage for this calculation is high.

Scenario range: ¥5.06 (bear) to ¥7.73 (bull), the price of ¥8.43 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Bluestar Adisseo Co reported revenue of 17.2B CNY in FY2025 versus 12.9B CNY in FY2021, a compound +7.6%/yr. Reported net income was 1.2B CNY in FY2025, compounding −5.9%/yr from FY2021.

Key figures

Market cap 25.8B CNY (≈ $3.9B) Mid · P/E ratio 13.4 · P/S ratio 1.34 · EPS (TTM) ¥0.6300 · Dividend yield 1.2% · Net margin 9.4% · Return on equity 9.8% · Return on assets (EBIT) 6.2% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 45% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at −30%, 600299 screens cheaper than that median.

Fair Value models

Bear ¥5.06 Fair Value ¥5.94 Bull ¥7.73

Price ¥8.43 · Downside -29.5%

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.4545 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Best data coverage

Residual Income ¥5.06 ¥5.22 ¥5.61 76

EPV ¥4.73 ¥5.37 ¥5.92 74

ROIC Compounder ¥4.73 ¥5.37 ¥5.92 72

All 16 models by family

Earnings-Based

Graham-Dodd ¥2.55 ¥10.87 ¥14.85 64

Lynch FV ¥2.78 ¥3.97 ¥5.16 61

PEG = 1.0 ¥2.78 ¥3.97 ¥5.16 57

EPV ¥4.73 ¥5.37 ¥5.92 74

Dividend Discount

Gordon GGM ¥1.71 ¥3.52 ¥5.52 66

DDM Multi-Stage ¥1.71 ¥2.98 ¥3.70 67

Multiples

P/E Multiple ¥4.78 ¥6.37 ¥7.97 63

P/S Multiple ¥4.78 ¥6.37 ¥7.97 58

P/B Multiple ¥10.44 ¥13.92 ¥17.40 55

EV/EBIT ¥6.49 ¥8.39 ¥10.30 66

EV/EBITDA ¥8.68 ¥11.32 ¥13.96 67

EV/Revenue ¥5.72 ¥7.85 ¥9.97 54

Asset-Based

NCAV (Graham) ¥0.3000 ¥0.4500 ¥0.5700 54

Economic Profit

Residual Income ¥5.06 ¥5.22 ¥5.61 76

ROIC Compounder ¥4.73 ¥5.37 ¥5.92 72

Growth Earnings

Growth-Adj P/E ¥4.16 ¥5.94 ¥7.73 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 36

How much profit the company makes from its sales and capital

Quality Growth 33

Are margins and returns getting better?

Cashflow 45

Do the profits arrive as real cash?

Financial strength 86

Debt, balance sheet and risk of trouble

Investment 35

Does it invest with discipline instead of growing at any price?

Low Volatility 69

How calm the share price moves, does not count

Price momentum 24

Price momentum of the last 3 to 12 months, does not count

Near the 52-week high 17

Distance to the 52-week high, does not count

New shares 81

Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 37/100

The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Revenue growth 1 year

+10.9%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+5.8%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+7.7%

Start year 2020 (pandemic). Over 10 years: +1.3% a year

Revenue growth 28 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+16.5%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

−1.9%

Earnings growth per share plus dividend.

Earnings per share, growth per year−3.1%

Dividend (yield on the price)1.2%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−3.1% vs −2.9%, steady

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 10%

Pace: the 5-year rate starts in 2020 (pandemic)

⚠ Revenue per share shrinking 2.4%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

600299 screens overvalued: fair value 30% below the price. Compare with Linde plc →

Compare Bluestar Adisseo Co with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks

Beats the industry median on 10/13 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 53 · Below median

Fair Value upside −30.8% · Below median

Profitability

Return on equity (12 months) 9.8% · Above median

Return on assets 4.2% · Above median

Net margin (12 months) 9.4% · Above median

Operating margin (12 months) 20.7% · Top 25%

Growth and dividend

Revenue growth (quarter YoY) 26.1% · Above median

Dividend yield (12 months) 1.2% · Below median

Balance sheet

Debt / equity 0.08× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 13.4× · Cheaper than median

P/B 1.32× · Cheaper than median

P/S (12 months) 1.34× · Cheaper than median

EV/EBITDA 6.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 0

FUTURE (revenue growth)100 · sector 67

PAST (return on equity)39 · sector 27

HEALTH (low debt)96 · sector 95

DIVIDEND (yield)23 · sector 31

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value	Compare
Nan Ya Plastics Corporation 1303	263.00 TWD	420.80 TWD	+60%	vs 600299
Wanhua Chemical Group 600309	¥72.65	¥68.03	−6%	vs 600299
Linde plc LIN	$515.25	$446.62	−13%	vs 600299
PPG Industries, Inc PPG	$122.38	$77.68	−37%	vs 600299
DSM-Firmenich AG DSFIR	CHF 100.50	CHF 57.70	−43%	vs 600299
The Sherwin-Williams Company SHW	$344.10	$146.37	−57%	vs 600299
Givaudan SA GIVN	CHF 4,054	CHF 1,554	−62%	vs 600299
EMS-CHEMIE HOLDING AG EMSN	CHF 848.50	CHF 284.63	−66%	vs 600299
Ecolab Inc ECL	$300.68	$96.56	−68%	vs 600299
Air Products and Chemicals, Inc APD	$304.84	$75.33	−75%	vs 600299

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks Undervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator

Run the numbers yourself: free valuation calculators

DCF Calculator P/E Ratio Calculator PEG Ratio Calculator Graham Number Peter Lynch Formula DDM Calculator Intrinsic Value Intrinsic vs Extrinsic Value P/E Ratio by Sector

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Bluestar Adisseo Co: fair value per Fair Value Calculator

<a href="https://www.fairvalue-calculator.com/stock/600299?utm_source=embed&amp;utm_medium=badge" target="_blank" rel="nofollow noopener"><img src="https://www.fairvalue-calculator.com/embed/600299.SHG.svg" width="360" height="84" alt="Bluestar Adisseo Co: fair value per Fair Value Calculator" style="border:0;max-width:100%" loading="lazy"></a>

Cite: Fair Value Calculator (2026). "Bluestar Adisseo Co Fair Value". https://www.fairvalue-calculator.com/stock/600299

Frequently asked questions

Is Bluestar Adisseo Co (600299) overvalued or undervalued?

As of Nov 4, 2026, our model estimates a fair value of ¥5.94 versus a price of ¥8.43, about 30% lower (overvalued).

What is the fair value of 600299?

Our model-based fair value for Bluestar Adisseo Co is ¥5.94 (as of Nov 4, 2026), built from audited fundamentals. The current price: ¥8.43.

What is the quality score of 600299?

Bluestar Adisseo Co has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Bluestar Adisseo Co (600299)?

Our model-based price target is the fair value of ¥5.94 (as of Nov 4, 2026) from 16 valuation models. Cautious scenario ¥5.06, optimistic scenario ¥7.73. It is a calculation from audited fundamentals, not an analyst target.

What is the Bluestar Adisseo Co stock forecast for 2026?

Our models put fair value at ¥5.94, about 30% lower versus a price of ¥8.43 (overvalued). Cautious scenario ¥5.06, optimistic scenario ¥7.73. The calculation is refreshed regularly with new filings.

What is the revenue of Bluestar Adisseo Co (600299)?

Bluestar Adisseo Co reported trailing-twelve-month revenue of about 19.6B CNY (latest available figure, as of Nov 4, 2026).

Does Bluestar Adisseo Co pay a dividend?

Bluestar Adisseo Co currently shows a dividend yield of 1.19% relative to its recent price (as of Nov 4, 2026).

How much is the dividend of Bluestar Adisseo Co (600299) and when is the ex-dividend date?

Bluestar Adisseo Co pays a dividend of ¥0.1 per share a year, a dividend yield of 1.2%. The last ex-dividend date was Jul 10, 2026. The payout ratio is 15.9% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.

What is the intrinsic value of Bluestar Adisseo Co (600299)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bluestar Adisseo Co it is ¥5.94 per share (as of Nov 4, 2026), against a price of ¥8.43. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).

Is Bluestar Adisseo Co stock overvalued or undervalued in 2026?

As of Nov 4, 2026, 600299 trades above its calculated fair value: price ¥8.43, fair value ¥5.94, a gap of about −30% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 600299?

No. The price is what the market pays today (¥8.43); the fair value is what the company's own numbers justify (¥5.94). For Bluestar Adisseo Co the two are ¥2.49 per share apart. That gap is exactly why we show both numbers side by side.

How much is Bluestar Adisseo Co worth?

The market values Bluestar Adisseo Co at about 25.8B CNY (market capitalisation, as of Nov 4, 2026). Per share that is ¥8.43; our models calculate a fair value of ¥5.94 per share.

What do the bullish and bearish scenarios say about 600299?

Our models span a range for Bluestar Adisseo Co: cautious scenario ¥5.06, base ¥5.94, optimistic ¥7.73 per share (as of Nov 4, 2026, price ¥8.43). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 600299?

Bluestar Adisseo Co trades at a price-to-earnings ratio of 13.4 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥5.94 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, FY2025 ex one-offs: 22.6. Other multiples: P/B 1.3, P/S 1.3, EV/EBITDA 6.0.

How solid is the balance sheet of Bluestar Adisseo Co (600299)?

Balance-sheet figures for Bluestar Adisseo Co (as of Nov 4, 2026): return on equity 9.8%, debt of 0.08 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.

How far is 600299 from its 52-week high?

Bluestar Adisseo Co trades at ¥8.43, about 45% below its 52-week high of ¥15.46 and 15% above the low of ¥7.35 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of ¥5.94 is for.

Which stocks are comparable to Bluestar Adisseo Co?

From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Bluestar Adisseo Co stock attractive at the current price?

The data as of Nov 4, 2026: price ¥8.43, calculated fair value ¥5.94 (−30%), Quality Score 53/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 600299 calculated?

We run Bluestar Adisseo Co through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥5.94 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 13.3% above its aggregate fair value. Bluestar Adisseo Co itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Bluestar Adisseo Co (600299)?

The closing price on Nov 9, 2026 was ¥8.43. Our model-based fair value is ¥5.94, about 30% lower (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Bluestar Adisseo Co right now?

The price sits above even our optimistic bull case (¥7.73). The favourable scenario is already priced in. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.

Where does the earnings growth of Bluestar Adisseo Co (600299) come from?

Earnings per share at Bluestar Adisseo Co grew −7.7 % a year from 2014 to 2025. Broken into its drivers: revenue per share +0.0 %, EBIT margin −10.1 %, tax rate +2.3 %, residual (interest, one-offs) +0.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Bluestar Adisseo Co

How large is the market capitalisation of Bluestar Adisseo Co (600299)?

The market capitalisation of Bluestar Adisseo Co is 25.8B CNY (≈ $3.9B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Bluestar Adisseo Co (600299)?

The price-to-sales ratio of Bluestar Adisseo Co is 1.34 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Bluestar Adisseo Co (600299)?

Earnings per share at Bluestar Adisseo Co are ¥0.6300 (price ÷ EPS = P/E 13.4). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Bluestar Adisseo Co (600299)?

The dividend yield of Bluestar Adisseo Co is 1.2% (payout 15.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Bluestar Adisseo Co (600299)?

The net margin of Bluestar Adisseo Co is 9.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Bluestar Adisseo Co (600299)?

The return on equity (ROE) of Bluestar Adisseo Co is 9.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Bluestar Adisseo Co (600299)?

On an EBIT basis the return on assets of Bluestar Adisseo Co is 6.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Bluestar Adisseo Co (600299)?

The operating margin of Bluestar Adisseo Co is 20.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Bluestar Adisseo Co (600299)?

Revenue at Bluestar Adisseo Co is growing +26.1% versus a year earlier (3y avg +5.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Bluestar Adisseo Co (600299)?

Earnings per share at Bluestar Adisseo Co are growing +174% versus a year earlier. How much earnings per share grew versus a year earlier.

How much free cash flow does Bluestar Adisseo Co (600299) generate?

The free cash flow of Bluestar Adisseo Co is −372M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net cash does Bluestar Adisseo Co (600299) hold?

Bluestar Adisseo Co holds more cash than debt, 2.4B CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.

Free · no account needed

Watch Bluestar Adisseo Co in the live analysis

One click puts Bluestar Adisseo Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.